Clinical evaluation of dithiothreitol in comparison with sonication for biofilm dislodgement in the microbiological diagnosis of periprosthetic joint infection.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 31 10 2021
revised: 26 02 2022
accepted: 04 03 2022
pubmed: 9 4 2022
medline: 11 5 2022
entrez: 8 4 2022
Statut: ppublish

Résumé

Sonication of explanted devices is well investigated method and was shown to improve the microbiological diagnosis of impant-associated infections by physical removal of bacterial biofilms. Recently, novel approach with chemical agents have been investigated for biofilm dislodgement such as dithiothreitol (DTT). We compared the biofilm dislodgement efficacy of chemical method (dithiothreitol, DTT) compared to the sonication procedure in the diagnosis of prosthetic joint infections (PJI). In a prospective cohort, 187 patients undergoing hip and knee prostheses explantation were included, of whom 94 were assigned for sonication and 93 for DTT group. Sonication showed better sensitivity (73.8%) than DTT (43.2%) for the diagnosis of PJI and comparable specificity (98% and 94.6%, respectively). We concluded that sonication provides a more reliable diagnosis of PJI and detects about 30% more pathogens compared to DTT system. The study was registered at ClinicalTrials.gov (NCT02530229).

Identifiants

pubmed: 35395437
pii: S0732-8893(22)00047-5
doi: 10.1016/j.diagmicrobio.2022.115679
pii:
doi:

Substances chimiques

Dithiothreitol T8ID5YZU6Y

Banques de données

ClinicalTrials.gov
['NCT02530229']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115679

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Heraeus Medical (Hanau, Germany) provided the DTT diagnostic kits MicroDTTect system (4i Srl, Monza, Italy). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Svetlana Karbysheva (S)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Berlin Institute of Health Centre for Regenerative Therapies (BCRT), Berlin, Germany.

Sabrina Cabric (S)

Berlin Institute of Health Centre for Regenerative Therapies (BCRT), Berlin, Germany.

Anna Koliszak (A)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Maja Bervar (M)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Stephanie Kirschbaum (S)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Sebastian Hardt (S)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Carsten Perka (C)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Berlin Institute of Health Centre for Regenerative Therapies (BCRT), Berlin, Germany.

Andrej Trampuz (A)

Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Berlin Institute of Health Centre for Regenerative Therapies (BCRT), Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH